Equels Thomas K bought AIM
November 30, 2023 · Form 4 insider transaction
Equels Thomas K bought 300,000 shares of AIM ImmunoTech Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 118 days after the transaction.
Direction
Acquired (buy-side)
Shares
300,000
Price
$0.00
Total value
N/A
InsiderEquels Thomas K
Role—
CompanyAIM ImmunoTech Inc. (AIM)
SecurityOptions
Transaction codeA: Grant or award
Transaction dateNovember 30, 2023
Filing dateMarch 27, 2024
Shares owned after300,000
OwnershipDirect
10b5-1 planNo
AmendedNo